JP7877221B2 - 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用 - Google Patents

中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用

Info

Publication number
JP7877221B2
JP7877221B2 JP2022559927A JP2022559927A JP7877221B2 JP 7877221 B2 JP7877221 B2 JP 7877221B2 JP 2022559927 A JP2022559927 A JP 2022559927A JP 2022559927 A JP2022559927 A JP 2022559927A JP 7877221 B2 JP7877221 B2 JP 7877221B2
Authority
JP
Japan
Prior art keywords
cells
days
wnt
certain embodiments
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022559927A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520466A5 (cg-RX-API-DMAC7.html
JP2023520466A (ja
Inventor
ローレンツ ステューダー,
テ-ワン キム,
ソ-ヨン ク,
Original Assignee
メモリアル スローン-ケタリング キャンサー センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メモリアル スローン-ケタリング キャンサー センター filed Critical メモリアル スローン-ケタリング キャンサー センター
Publication of JP2023520466A publication Critical patent/JP2023520466A/ja
Publication of JP2023520466A5 publication Critical patent/JP2023520466A5/ja
Priority to JP2025160105A priority Critical patent/JP2025184905A/ja
Application granted granted Critical
Publication of JP7877221B2 publication Critical patent/JP7877221B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022559927A 2020-04-02 2021-04-02 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用 Active JP7877221B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025160105A JP2025184905A (ja) 2020-04-02 2025-09-26 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063004138P 2020-04-02 2020-04-02
US63/004,138 2020-04-02
PCT/US2021/025596 WO2021203009A1 (en) 2020-04-02 2021-04-02 Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025160105A Division JP2025184905A (ja) 2020-04-02 2025-09-26 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用

Publications (3)

Publication Number Publication Date
JP2023520466A JP2023520466A (ja) 2023-05-17
JP2023520466A5 JP2023520466A5 (cg-RX-API-DMAC7.html) 2024-04-11
JP7877221B2 true JP7877221B2 (ja) 2026-06-22

Family

ID=77929755

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022559927A Active JP7877221B2 (ja) 2020-04-02 2021-04-02 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用
JP2025160105A Pending JP2025184905A (ja) 2020-04-02 2025-09-26 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025160105A Pending JP2025184905A (ja) 2020-04-02 2025-09-26 中脳ドーパミンニューロンの生成方法、中脳ニューロンおよびその使用

Country Status (12)

Country Link
US (1) US20230143486A1 (cg-RX-API-DMAC7.html)
EP (1) EP4127137A4 (cg-RX-API-DMAC7.html)
JP (2) JP7877221B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220164012A (cg-RX-API-DMAC7.html)
CN (1) CN115768875A (cg-RX-API-DMAC7.html)
AU (1) AU2021248640A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022019881A2 (cg-RX-API-DMAC7.html)
CA (1) CA3177525A1 (cg-RX-API-DMAC7.html)
IL (1) IL296919A (cg-RX-API-DMAC7.html)
MX (1) MX2022012366A (cg-RX-API-DMAC7.html)
WO (1) WO2021203009A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202211266B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023220639A2 (en) * 2022-05-10 2023-11-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for improved memory in the aging
WO2024259119A2 (en) 2023-06-13 2024-12-19 Aspen Neuroscience, Inc. Methods for differentiating dopaminergic neurons from stem cells
AU2025217196A1 (en) 2024-01-31 2026-07-09 Bluerock Therapeutics Lp Igfbp2 in cell culture
WO2025252180A1 (zh) * 2024-06-05 2025-12-11 中国科学院脑科学与智能技术卓越创新中心 中脑多巴胺能祖细胞群的体外制备方法
WO2026006245A1 (en) * 2024-06-25 2026-01-02 Bluerock Therapeutics Lp Three-dimensional culturing of pluripotent stem cells for improved differentiability
WO2026096366A1 (en) 2024-10-28 2026-05-07 Bluerock Therapeutics Lp Compositions and methods for determination of pluripotent stem cell differentiability
CN121759465B (zh) * 2026-03-05 2026-07-14 上海元戊医学技术有限公司 兼具条件性免疫逃逸功能和自杀功能的神经细胞、其建立方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012332269B2 (en) * 2011-11-04 2018-05-31 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (DA) neurons for engraftment
EP2614829A1 (en) * 2012-01-11 2013-07-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons
CN105209607B (zh) * 2013-04-05 2020-02-07 大学健康网络 产生软骨细胞谱系细胞和/或类软骨组织的方法和组合物
JP6756610B2 (ja) * 2013-04-26 2020-09-16 メモリアル スローン ケタリング キャンサー センター 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞
SG11201807487WA (en) * 2016-03-14 2018-09-27 Agency Science Tech & Res Generation of midbrain-specific organoids from human pluripotent stem cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Stem Cells,2020年02月28日,Vol.38,No.6,p.727-740
The Journal of Clinical Investigation,2020年02月03日,Vol.130,No.2,p.904-920

Also Published As

Publication number Publication date
WO2021203009A1 (en) 2021-10-07
EP4127137A4 (en) 2024-05-22
KR20220164012A (ko) 2022-12-12
ZA202211266B (en) 2023-05-31
US20230143486A1 (en) 2023-05-11
CA3177525A1 (en) 2021-10-07
MX2022012366A (es) 2022-12-15
EP4127137A1 (en) 2023-02-08
CN115768875A (zh) 2023-03-07
JP2025184905A (ja) 2025-12-18
BR112022019881A2 (pt) 2022-11-22
IL296919A (en) 2022-12-01
JP2023520466A (ja) 2023-05-17
AU2021248640A1 (en) 2022-10-27

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240401

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250519

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250926

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260318

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260513

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260610

R150 Certificate of patent or registration of utility model

Ref document number: 7877221

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150